Effects of medroxyprogesterone acetate (MPA) in activating progesterone receptor signaling in benign- and cancer-associated fibroblasts of the endometrium
Medroxyprogesterone acetate (MPA) is used for conservative treatment for endometrial cancer (EC); however, patients often develop progesterone resistance. Most typical and atypical endometrial hyperplasia shows…

